Last reviewed · How we verify

NCT06717529

Functional and Clinical Outcomes of Hyaluronic Acid and Steroid Injections in Bilateral Knee Osteoarthritis

Completed Phase 4 Last updated 5 December 2024
What this trial tests

Phase 4 trial testing Sodium hyaluronate (hyaluronic acid) in Osteoarthritis (OA) of the Knee in 65 participants. Completed in 30 September 2024.

Timeline
1 January 2023
Primary endpoint
15 November 2023
30 September 2024

Quick facts

Lead sponsorEdin Mešanović
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment65
Start date1 January 2023
Primary completion15 November 2023
Estimated completion30 September 2024
Sites1 location across Bosnia and Herzegovina

Drugs / interventions tested

Conditions studied

Sponsor

Edin Mešanović

Who can join

18 and older, any sex, with Osteoarthritis (OA) of the Knee or Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to compare functional and clinical outcomes of intraarticular injections of hyaluronic acid and steroids in patients with bilateral knee osteoarthritis. We will compare clinical and functional outcomes for each knee separately after week 6, month 3, month 6, and one year after the intervention.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Osteoarthritis (OA) of the Knee

Currently open trials in the same condition.

Other Edin Mešanović trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06717529.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing